Customization of therapy for gastroesophageal adenocarcinoma patients

Gastroesophageal adenocarcinomas (GEACs) remain a global health problem. These are most often diagnosed at advanced stage and the estimated 5-year relative survival rate is about 5%. Although cure is not possible for patients with advanced GEAC, systemic therapy (chemotherapy or biochemotherapy) can...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizrak Kaya, Dilsa, Harada, Kazuto, Amlashi, Fatemeh G., Vasilakopoulou, Maria, Ajani, Jaffer A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association 2018
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938285/
https://www.ncbi.nlm.nih.gov/pubmed/29756119
http://dx.doi.org/10.1016/j.cdtm.2018.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938285/
https://www.ncbi.nlm.nih.gov/pubmed/29756119
http://dx.doi.org/10.1016/j.cdtm.2018.02.003

Ejemplares similares